Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabbri

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Pharmaceutics|October 27, 2022
Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer PatientsLuigi Pasini, Ivan Vannini, Paola Ulivi, et al.
The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Anti-Cancer Drugs|September 16, 2009
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell linesIvan Vannini, Wainer Zoli, Francesco Fabbri, et al.
Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.
International Journal of Oncology|February 14, 2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell linesToni Ibrahim, Chiara Liverani, Laura Mercatali, et al.
Oncotargets and Therapy|October 17, 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapySilvia Carloni, Giulia Gallerani, Anna Tesei, et al.
Journal of Cellular Physiology|March 17, 2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell linesPaola Ulivi, Chiara Arienti, Dino Amadori, et al.
Journal of Translational Medicine|November 1, 2007
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesAnna Tesei, Marco Rosetti, Paola Ulivi, et al.
American Journal of Physical Anthropology|July 2, 2016
Middle paleolithic human deciduous incisor from Grotta del Cavallo, ItalyPier Francesco Fabbri, Daniele Panetta, Lucia Sarti, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 16, 2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesMarco Rosetti, Anna Tesei, Paola Ulivi, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Pharmaceutics|October 27, 2022
Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer PatientsLuigi Pasini, Ivan Vannini, Paola Ulivi, et al.
The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Anti-Cancer Drugs|September 16, 2009
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell linesIvan Vannini, Wainer Zoli, Francesco Fabbri, et al.
Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.
International Journal of Oncology|February 14, 2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell linesToni Ibrahim, Chiara Liverani, Laura Mercatali, et al.
Oncotargets and Therapy|October 17, 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapySilvia Carloni, Giulia Gallerani, Anna Tesei, et al.
Journal of Cellular Physiology|March 17, 2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell linesPaola Ulivi, Chiara Arienti, Dino Amadori, et al.
Journal of Translational Medicine|November 1, 2007
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesAnna Tesei, Marco Rosetti, Paola Ulivi, et al.
American Journal of Physical Anthropology|July 2, 2016
Middle paleolithic human deciduous incisor from Grotta del Cavallo, ItalyPier Francesco Fabbri, Daniele Panetta, Lucia Sarti, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 16, 2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesMarco Rosetti, Anna Tesei, Paola Ulivi, et al.
Pageof 10